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Abstract
Background: Cancer risk assessment tools are designed to help detect cancer risk 
in symptomatic individuals presenting to primary care. An early detection of cancer 
risk could mean early referral for investigations, diagnosis and treatment, helping to 
address late diagnosis of cancer. It is not clear how best cancer risk may be commu-
nicated to patients when using a cancer risk assessment tool to assess their risk of 
developing cancer.
Objective: We aimed to explore the perspectives of service users and primary care 
practitioners on communicating cancer risk information to patients, when using 
QCancer, a cancer risk assessment tool.
Design: A qualitative study involving the use of individual interviews and focus 
groups.
Setting and participants: Conducted in primary care settings in Lincolnshire with a 
convenience sample of 36 participants (19 service users who were members of the 
public) and 17 primary care practitioners (general practitioners and practice nurses).
Results: Participants suggested ways to improve communication of cancer risk infor-
mation: personalizing risk information; involving patients in use of the tool; sharing 
risk information openly; and providing sufficient time when using the tool during 
consultations.
Conclusion: Communication of cancer risk information is complex and difficult. We 
identified strategies for improving communication with patients involving cancer risk 
estimations in primary care consultations.
K E Y W O R D S
cancer risk assessment tools, cancer risk communication, general practitioners, primary care, 
QCancer, service user views
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1  | BACKGROUND
Delayed diagnosis of cancer can adversely affect treatment options, 
outcomes such as survival and quality of life, and costs.1-3 To tackle 
late diagnosis of cancer, there has been an increased interest in the 
use of cancer risk assessment tools to identify and quantify cancer 
risk in symptomatic individuals during primary care consultations.4-7
Two cancer risk assessment tools designed for symptomatic in-
dividuals and available in primary care are QCancer5-7 and the Risk 
Assessment Tool [RAT].4 Both QCancer and RAT were developed, 
tested,4,5 and QCancer in particular has been independently val-
idated,8,9 as accurately quantifying risk of cancer in primary care. 
Despite this, it is currently not clear how cancer risk information 
generated through use of the tools can be effectively communicated 
to patients.
Current evidence suggests that discussion of risk information 
was less likely to occur if patients did not prompt practitioners.10 In 
a recent review of the literature around cancer risk assessment tools 
in primary care, a key challenge identified was how best to commu-
nicate risk information to patients11 without causing undue anxiety 
or worry to patients.
Exploring ways to best communicate cancer risk to patients is 
important as the NHS cancer plan advocates effective communi-
cation between health professionals and patients, which can facil-
itate the delivery of high-quality care and empower people to be 
involved in decisions about their care.12 While there is existing liter-
ature about communicating and sharing decisions with people who 
have cancer,13 most communication evidence relates to people with 
existing cancer, but is not directly related to the use of cancer risk 
assessment tools designed for individuals with symptoms reporting 
to primary care who may not yet be aware of their cancer status. In 
fact, recent research in this area indicates cancer decision support 
tools which include QCancer are not being widely used.14
The aim of this study was to explore the views of service users 
and primary care practitioners on how best to communicate cancer 
risk information when using QCancer, a cancer risk assessment tool, 
with symptomatic individuals in primary care consultations to enable 
them be involved in decisions on referral and cancer investigations. 
QCancer was used as a reference tool because it has been validated 
externally.8,9
2  | METHODS
2.1 | Design and setting
We used a qualitative design employing semi-structured individual 
interviews and focus groups. The study took place in Lincolnshire in 
the East Midlands region of England during 2016. Ethical approval 
for the study was granted by the School of Health and Social Care 
Ethics Committee, University of Lincoln.
The eight stages of the Risk Analysis Framework15 informed the 
development of the topic guide for the interviews, the analysis and 
interpretation of the data as well as the discussion of the findings. 
The framework recognizes that a combination of some or all of the 
stages is important for effectively communicating risk to patients.15 
The eight stages are (to some extent ironically) stated as follows: (a) 
Get the numbers right; (b) Tell them the numbers; (c) Explain what 
the numbers mean; (d) Show them that they have accepted similar 
risks in the past; (e) Show them that it is a good deal for them; (f) 
Treat them nicely; (g) Make them partners; and (h) Combine all the 
stages. The Risk Analysis Framework was selected to inform the de-
velopment of the topic guides (for the interviews and focus groups), 
the analysis and interpretation of the data, because the various 
stages of the framework served as a suitable theoretical background 
for explaining how best cancer risk can be communicated to a pa-
tient during consultations.
2.2 | Recruitment of participants and data collection
We recruited a convenience sample of service users and pri-
mary care practitioners (GPs and practice nurses) for the study. 
Table 1 presents the characteristics of participants with regard 
to age group, gender and ethnicity. Service users were recruited 
TA B L E  1   Participant characteristics
 Service users Practitioners
Gender
Male 7 13
Female 12 4
Age group
20-29 3 —
30-39 4 3
40-49 1 10
50-59 3 4
60-69 5 —
70-79 3 —
Ethnicity
White British 19 6
Indian — 6
Pakistani — 3
Asian British — 1
Bangladeshi — 1
Practice patient list size
200-2900 — 1
3000-3900 — —
4000-4900 — —
5000-5900 — —
6000-6900 — 8
7000-7900 — —
8000-8900 — —
9000-9900 — 8
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using flyers placed at public places including community centres 
and libraries in the study area and through a patient and public 
involvement group.
Our sample of service users included adults who did not have 
active cancer but could potentially present to general practice 
with symptoms suggesting cancer, where a clinician might use the 
tool during the consultation. Patients with known cancer were not 
included because the cancer risk assessment tool of interest is 
designed to help detect risk of cancer in symptomatic individuals 
and would not be used in the presence of known cancer. Although 
patients with cancer could have provided useful views, we did 
not include them because of the potential stress of taking part. 
Similarly, our sample of practitioners included GPs and practice 
nurses who usually see patients who present to general practice 
with symptoms which could be those of cancer. We checked with 
service users and confirmed that they were adults and had no ac-
tive cancer at the time of being interviewed. We also confirmed 
with practitioners that they worked in general practices in the 
study area and were involved in patient consultations, particularly 
for practice nurses.
Interested service users contacted the researcher (JNA) for 
more information and to arrange a suitable date and time for 
individual interviews. Interviews were conducted either in ser-
vice users’ own homes or at the university. Individual interviews 
were used for service users as it was not possible to meet them 
in groups.
Primary care practitioners were invited to participate through 
local general practices. Interested practitioners contacted the re-
searcher for more information, and to arrange a date and time for 
either individual interviews or focus groups. Practitioners whose 
schedules did not allow them to meet in groups were offered indi-
vidual interviews instead. Groups of practitioners in practices who 
agreed to be interviewed together were offered a focus group.
At the beginning of interviews and focus groups with partici-
pants, a vignette of how the QCancer tool (the reference tool for 
this study) works was shown to participants. Where there was 
Internet access, the researcher (JNA) demonstrated how QCancer 
worked. Where Internet access was unavailable, the vignette was 
explained in terms of how an individual's risk factors and symp-
toms could be entered in the QCancer tool to calculate a cancer 
risk represented by blue sad faces (those at risk of having can-
cer within two years) and yellow smiley faces (those not at risk 
of cancer) as shown in Figure 1. After showing and explaining or 
demonstrating the vignette to participants, questions were asked 
to explore views on how best cancer risk information could be 
communicated to patients.
Prior to starting the individual interviews and focus groups, 
participants were asked to give written consent and were as-
sured that they were free to discontinue the interview or focus 
group at any point. With permission of the participants, the in-
terviews and focus groups were audio recorded and later tran-
scribed verbatim. Notes were also taken which complemented 
the audio-recorded data.
2.3 | Data analysis
Data were transcribed verbatim and analysed using the framework 
approach16 facilitated by NVivo version 10. A priori codes derived 
from the Risk Analysis Framework informed the interview guide, 
analysis and interpretation by providing an initial coding framework 
of deductive themes arising from the relevant parts of the Risk 
Analysis Framework such as ‘get the numbers’, ‘tell them the num-
bers’, ‘explain what the numbers mean’, ‘treat them nicely or with 
respect’ and ‘make them partners’.
Further inductive codes were identified from the data. This in-
volved the following steps. Two investigators (JNA and ANS) read 
and re-read transcripts to derive an initial coding framework which 
was discussed and agreed by the wider research team. Initial de-
scriptive themes were developed by organizing codes. These were 
developed iteratively through further interpretation and discussion 
into a smaller number of overarching themes. For both service users 
and practitioners, data were collected and analysed until saturation 
was achieved; that is, no new codes or meaning were identified.17 
Data from service users and practitioners were analysed separately 
and then compared to determine the extent to which these views 
agreed or differed.
2.4 | Patient and public involvement
The research questions, the study design and interview guides were in-
formed through discussion with the Healthier Aging Patient and Public 
Involvement (HaPPI) group at the University of Lincoln. Members of 
the HaPPI group also helped with recruitment of service users, helping 
to identify and distribute the study flyers to interested participants.
3  | RESULTS
3.1 | Participants
We interviewed 36 participants, 19 service users (aged 21 to 
71 years) and 17 practitioners (aged 33 to 55 years) as presented 
in Table 1. Of the 19 service users, two had a previous diagnosis 
of cancer, and the rest had relatives or friends who had a previous 
diagnosis of cancer.
3.2 | Themes
The analysis produced four overarching themes which addressed 
the research question on how best to communicate cancer risk 
information to patients when using a cancer risk assessment tool. 
Participants felt that effective communication of cancer risk infor-
mation between patients and practitioners when using cancer risk 
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assessment tools was important, and that this could be enhanced in 
the following ways: personalizing risk information; involving patients 
when using the tools; being open and honest; and providing time for 
listening, informing, explaining and reassuring patients in a profes-
sional manner.
3.2.1 | Theme 1: Personalizing risk information
This theme relates to the risk communication framework concepts 
of telling patients and explaining to their level of understanding 
of what the cancer risk information means. It also relates to the 
notion that seeing a pictorial illustration of a phenomenon like 
cancer risk makes the explanation less abstract and enhances un-
derstanding of the information being presented to the individual. 
Indeed, participants felt that personalizing the risk information 
could help individual patients to understand the risk information 
being communicated to them. For example, using pictures suitable 
to individual patients to explain risk information to them was felt 
to make the information less abstract and easier for patients to 
understand. One service user said:
I really like this. I like the pictorial representation, I like 
the fact that it is simple but it's effective because it draws 
you really right to the point. You know the happy smiley 
and sad faces can get you an idea. I think it is simple and 
clear so most people will be able to understand this and 
take that information on board as opposed to if the doc-
tor just mentions cancer risk, it will put you off. But if you 
look at this and they talk you through this I think that will 
be really useful. 
(Service User 12: individual interview)
Practitioners generally agreed with this view that personalizing risk 
could enhance patients’ understanding of risk information, but some 
practitioners felt that the icon arrays used in QCancer could be improved, 
by arranging them together in rows rather than scattered throughout the 
diagram (see Figure 1). In line with this, one practitioner said:
I like the smiley faces as well, it's a good way of showing 
things. But I think it should be lined not random. I will like 
the blue sad faces to be in line, in a row, otherwise if they 
are scattered it gives the impression that they are many 
when they are not. And it's easier to read when they are 
lined in rows. 
(Practitioner 11 [GP]: Focus Group 2)
3.2.2 | Theme 2: Informing and involving patients
This theme relates to the risk communication framework stage of 
explaining to patients what cancer risk means and suggests that if 
cancer risk information is not explained, patients are less likely to 
feel informed or understand the information, which could make 
them more anxious, less reassured, and they may lose trust in the 
clinician.
Practitioners explained their approach to informing patients. 
One stated:
F I G U R E  1   Vignette (example) of 
QCancer risk scores
No cancer 86.83% represented by the yellow smiley faces
Any cancer 13.17% represented by the blue sad faces
Estimates for the individual 
cancers:
Ovarian 9.16%
Other 1.46%
Colorectal 0.58%
Pancreac 0.55%
Gastro-oesophageal 0.43%
Lung 0.41%
Breast 0.24%
Renal tract 0.11%
Blood 0.11%
Cervical 0.09%
Uterine 0.04%
Your QCancer
®
score 13.17%
The score of a typical person with the same age and sex
* 0.79%
Relave risk
** 16.7
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We just discuss something like - I am worried about this, 
something sinister, it could be cancer and…. we would 
like to do a referral, urgent referral for you. That's how we 
try to explain to the patient. For any other risk, like we do 
for heart disease. 
(Practitioner 11 [GP]: individual interview)
Service users felt that it would be helpful to see practitioners 
using the tools, allowing them to see the information displayed on the 
computer screen which would help practitioners to explain, and en-
hance their understanding and involvement. One service user stated:
I will like to be involved and I will like to see them using 
the tool. I will like to see the smiley faces on the screen, 
and I will expect them to then explain to me what the 
results mean in terms of my risk. 
(Service User 15: individual interview)
Service users felt that practitioners should avoid difficult medical 
terms and convey information at a level appropriate to the service user:
Yes, you wouldn't want them to speak in difficult medical 
terms; you would want them to bring it down to the level 
of the person you're speaking to. 
(Service User 14: individual interview)
Some service users preferred being told that the tool was being 
used even if that increased their worry when risk information was 
being shared:
They probably telling you is better. A better way of using 
it [the tool] is that you should be told that they are using 
it. Even though that will still make you worry, I think that 
if it were something to worry it will be slightly different 
anyway. 
(Service User 1: individual interview)
Several practitioners expressed the view that patients should be 
told that the tool was being used to calculate risk:
If you don't tell them before using the tool it means you 
are not being honest. I mean you can't do anything with-
out telling the patient, you need their consent. 
(Practitioner 4 [GP]: individual interview)
Practitioners admitted, ‘talking about risk is quite difficult’ 
(Practitioner 3 (GP): Focus Group 1), and remarked on observing 
patient's reactions to check, ‘do the patients actually understand 
me, what I am trying to tell them?’ (Practitioner 3 [GP]: Focus 
Group 1).
In contrast, one practitioner thought they may be reluctant to 
inform the patient about cancer risk when they themselves were un-
certain about the risk calculated or how to communicate this:
I think the only time you might do it without informing 
the patient is when you are uncertain, you might go back 
and use it and then call the patient and inform them 
when you are sure of the risk. 
(Practitioner 12 [GP]: Focus Group 3)
3.2.3 | Theme 3: Being open and honest
Being open and honest relates to the risk communication framework 
stage of treating patients with respect, which underlines the impor-
tance of recognizing the right of individuals to know the truth about 
their health information, as far as possible and in the interests of the 
individual.
Participants felt that being open and honest, including being told 
that a cancer risk assessment tool was being used, what the result 
was and what it meant for the individual patient, would help to avoid 
misunderstanding, whereas not telling patients the truth could af-
fect trust between patients and practitioners. This was reflected in 
the following comments:
When I go to the doctor I expect to be honest with them 
and be clear as best as I can and you would expect the 
same from the practitioner, open conversation, open de-
tails from both sides to avoid misunderstanding. 
(Service User 19: individual interview)
Specifically, service users felt it was important to know the im-
plications of a quantified cancer risk including whether they had a 
chance of not getting cancer or surviving cancer if they were diag-
nosed with the condition, even if this led to increased worry. A ser-
vice user said, ‘I will like to be told the truth about what this 10% 
means and whether I've got a chance’ (Service User 3: individual 
interview).
Similar to the views of service users, a practitioner said:
I will be quite open and honest with them that, you've 
come with these symptoms, some of them are already 
in, and we can use the tool to work out what it is. If 
you bear with me I will check your risk and I could put 
those figures and what is coming out is your risk, and 
we can try that. 
(Practitioner 11 [GP]: Focus Group 2)
3.2.4 | Theme 4: Providing time for listening, 
explaining and reassuring in the context of a 
professional approach
In relation to the risk communication framework stage of explain-
ing to patients what risk information means, the provision of time 
for listening, explaining and reassuring patients in a professional 
way was expressed by participants as important for conveying 
6  |     AKANUWE Et Al.
cancer risk information. Indeed, service users felt that practition-
ers should take time to talk to patients to gain their confidence and 
show they cared:
You wouldn't want to feel that you've been rushed, you 
would want them to take time to talk with you, and if 
they try to cut this conversation short you would think 
that they didn't care, and again that could reduce your 
confidence. 
(Service User 12: individual interview)
Practitioners also expressed the need to provide more time to pro-
vide explanations to patients:
What I feel is, I would try and give as much time as possi-
ble and be as accurate as possible. 
(Practitioner 1 [GP]: individual interview)
Service users appreciated that practitioners would need longer 
consultations:
Practitioners in general practice would need more time to 
use the tools in consultations. 
(Service User 7: individual interview)
Practitioners felt that this could be achieved by including cancer 
risk assessment tools in consultation software such as SystmOne, a 
commonly used general practice software package. 
But we can target and do what we need, so unless we re-
ally suspect cancer. Also, it's time consuming but I think it 
will be quite quick if QCancer could be part of SystmOne. 
(Practitioner 11 [GP]: Focus Group 1)
4  | DISCUSSION
4.1 | Main findings
We found a range of ways of improving how cancer risk information 
could be communicated to patients during primary care consulta-
tions. These included the following: personalizing risk information 
arising from the use of a cancer risk assessment tool; informing and 
involving patients when using the tool; sharing risk information 
honestly; and providing sufficient time for listening, explaining and 
reassuring patients in the context of a professional approach. Some 
findings contradicted others; for example, uncertainty about risk 
led to reluctance to openly and honestly share information.
The views of participants in this study mapped closely to the 
stages of the risk communication framework. Although participants 
in the study had not actually used the tools in practice, their views 
were based on a vignette explaining how the tool would work in 
practice. This means that practitioners can draw on the framework 
and the findings of this study to aid effective communication of can-
cer risk in this context.
A novel outcome of this study is the use of the views of service 
users and practitioners to inform how to communicate with patients 
when using cancer risk assessment tools during general practice 
consultations.
4.2 | Comparison with existing literature
This study adds to previous evidence on the importance of per-
sonalizing information to suit the educational level, cultural 
background and the general level of understanding of individual 
patients,18 as many patients, including those with cancer, prefer 
information specific to them (such as that derived from their own 
medical records) rather than more general information.19 It also 
supports previous evidence that use of simple visual aids can en-
hance doctor–patient communication,20 relating to the risk com-
munication framework stage of telling patients and explaining 
what risk information means.15 Dikomitis and colleagues21 found 
problems in the design of electronic decision support tools, re-
sulting in a recommendation for further development of these 
tools to make them more user friendly, and evidence from a sys-
tematic review suggested that communication tools were more 
likely to increase patients’ understanding if they were more struc-
tured and interactive, with illustrations such as bar charts, help-
ing to convey understanding more than other types of graphical 
representation.22
In another systematic review investigating design features 
of graphs in health risk communication,23 there was evidence of 
patients being more able to recognize proportions with part-to-
whole sequential icon arrays (ie icons arranged in an ordered pat-
tern)24 than randomly arranged icon arrays,25 or jittered icons (ie 
small unsteady or difficult to visualize icons).26 This may explain 
the dislike of random-arrangement arrays found in this study and 
also reported in a previous qualitative study.27 Participants thought 
that scattering blue ‘sad’ faces gave the impression that they were 
more numerous, that the risk perceived was higher, and that bet-
ter structured graphics would ensure a visual representation which 
was clearer and easier for patients to understand. The importance 
of such design features supports the notion that the design charac-
teristics of an intervention can help its implementation.28
The literature on communicating results of (asymptomatic) 
screening is also sparse but highlights the importance of timely 
and effective communication, preferably verbal and face-to-face 
(rather than by letter or face-to-face) on patient understanding al-
though the findings for anxiety or worry were mixed.29 Providing 
accurate information and sharing decision making overall in-
creased uptake of screening behaviour.30 The other key differ-
ence with screening asymptomatic individuals is the presumption 
that the Wilson–Jungner criteria31 have been met for the screen-
ing test, whereas there has been limited evidence presented of 
the outcomes of cancer risk assessment tools in terms of their 
     |  7AKANUWE Et Al.
acceptability, feasibility, false negatives and false positives and 
survival or patient experience outcomes.
Although service users in our study did not express difficulty in 
understanding the QCancer risk information, difficulty for some pa-
tients in understanding numbers could also complicate risk commu-
nication.32 Around 40% of high school graduates in one study could 
not perform basic numerical operations, such as converting 1% of 
1000 to 10 out of 1000, presenting a major barrier to understanding 
or interpreting health statistics.33 Physicians may also find statisti-
cal information difficult to interpret and explain,34 and some prac-
titioners in our study did express uncertainty about the percentage 
threshold at which to refer a patient.
Being open and honest when conveying cancer risk to patients 
was another communication strategy cited as important by ser-
vice users and practitioners. That is, being open and honest has a 
potential to increase trust and reassurance, despite the potential 
to increase worry. Truthfulness relates to the risk communication 
framework stage of treating patients with respect,15 which is ethi-
cally important, contributing to building trust between patients and 
practitioners, as well as promoting patient autonomy and empower-
ment. Practitioners are required to communicate effectively, which 
includes delivering bad news and sharing required information in a 
professional and responsible manner.35
We found no demographic differences in the views of either ser-
vice user or clinician participants on telling patients the truth about 
their cancer risk, although a recent study found both similarities and 
differences in preferences of men and women for truth-telling and 
decision making.36 According to Chen et al, men and women had 
similar views of wanting to know about their medical condition, di-
rect and frank truthfulness, and assistance in decision making for 
treatment. Truth-telling differed by gender in the following ways: 
women wanted family members present for confirmation of diag-
nosis, whereas men did not; men preferred truth-telling for only key 
points of their cancer, whereas women wanted detailed information; 
and men did not want to know their survival period, whereas women 
wanted this information.36
When using a cancer risk assessment tool, although a few service 
users did not mind if they were not informed and some practitioners 
felt they might not inform patients in some circumstances, most 
participants agreed that to effectively communicate cancer risk, pa-
tients should be informed and involved in the use of a cancer risk 
assessment tool during the consultation. This position of informing 
and involving patients in the use of the tool supports the notion 
that people need to be informed about their health-care options.13 
It also relates to the risk communication framework stage of making 
patients partners in the use of a cancer risk assessment tool.15
Patient involvement here refers to the participation of patients 
in making shared decisions about their care including referral for 
further cancer investigations, diagnosis and treatment.37-39 When 
sharing cancer risk information with patients, clinicians need to 
observe and check patients’ reactions to assess their level of un-
derstanding and the extent to which they want to be involved in 
making decisions.40 Practitioners can sometimes underestimate 
the degree to which patients wish to be informed about or involved 
in decisions about their health41; that is, decisions are sometimes 
made assuming what patients prefer,42 rather than involving them 
in the decision-making process. If patients were not informed when 
a cancer risk assessment tool was being used, this could detract 
from gathering their views or preferences in the decision-making 
process, as some patients may want to be informed about available 
options but may not want to be involved in the entire decision.43 
It could also depart from the more widespread acknowledgement 
that people should be enabled to be involved in decisions about 
their care.13 Participants in this study, both service users and prac-
titioners, agreed that practitioners should involve patients during 
consultations when using a cancer risk assessment tool.
Providing time for listening, informing, explaining and reassur-
ing patients in the context of a professional approach was also 
cited by participants as important for improving effective com-
munication. As resources and time are often limited in general 
practice, the emphasis here is on practitioners working within 
time constraints to explain risk information, as far as possible, to 
enhance patients’ understanding as insufficient time could impair 
the quality of communication. This supports the argument for ex-
tending the ten minute consultation in general practice to accom-
modate additional tasks such as using a cancer risk assessment 
tool. This relates to the risk communication framework stage of 
explaining to patients what the cancer risk information means,15 
and importantly, making clear that a risk of cancer is not the same 
as a diagnosis of cancer. From the perspective of service users 
and practitioners in this study, not listening or not making efforts 
to explain issues to patients could adversely affect an otherwise 
trusted patient–practitioner relationship.
Practitioners should explain using lay terms rather than techni-
cal medical expressions which could leave patients feeling worried 
and anxious, not understanding what options are available, or with 
erroneous expectations of possible benefits and harms. A previous 
systematic review showed that when patients use decision aids, 
they improve their knowledge of the available options; are helped 
to have more accurate expectations of possible benefits and harms 
or barriers; positively affect communication with their health prac-
titioner; and reduce time required for the consultation.44
The Risk Analysis Framework15 provided an initial framework for 
the analysis16 although some findings overlapped with more than 
one concept in the framework and other findings suggested that 
communication was more complex than the framework suggested. 
For example, although calculating risks correctly (‘getting the num-
bers right’), communicating and explaining the risks (‘telling the 
numbers and explaining what they mean’) were supported to a large 
extent by our findings, it can be seen that how cancer risk was com-
municated was a much more complex task. Similarly, risks of cancer 
may be perceived differently to other risks and the decision to act or 
defer action and how to do this in a way that is ethical, benefits the 
patient and supports their autonomy is likely to be different for each 
interaction depending on the perception of the patient and clinician 
and the relationship between them.
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4.3 | Strengths and limitations
The data collection strategy was flexible allowing the use of individ-
ual interviews (which provided information from service users and 
practitioners) and focus groups which facilitated the collection of di-
verse and detailed information from practitioner colleagues who de-
cided to meet in a group, rather than being interviewed individually. 
Individual interviews provided time for clinicians to provide in-depth 
information, prompted by the interviewer and topic guide, whereas 
the clinician focus groups benefitted from interaction and discussion 
between participants.
A key strength of the study was that service user and practitioner 
perspectives could be compared to highlight areas of agreement and 
disagreement between them. Another strength of the study was the 
achievement of data saturation in codes (ie no new ideas expressed 
by participants) and meaning (ie all ideas expressed were under-
stood during the interpretation).17 We followed the Consolidated 
Criteria for Reporting Qualitative Studies45 (see Table S1), to ensure 
transparency and trustworthiness in reporting our research.
One limitation was that all nineteen service user participants 
were of White British ethnicity. The lack of representation from 
ethnic minority people is a limitation because GPs could use cancer 
risk tools with these patients and their views would be relevant and 
important. Although study publicity was circulated widely, it is pos-
sible that people from ethnic minority groups did not see the adver-
tisement, were unable to understand it due to language difficulties, 
or had less interest in participating in the study. Previous research 
suggests that members of minority ethnic groups are less likely to 
participate in research studies if they lack confidence in language 
or understanding of the topic being researched.46-48 They are more 
likely to participate if they are approached with sensitivity and they 
perceive the study to be beneficial.46,49
4.4 | Implications for practice and research
News about cancer risk could cause undue anxiety or worry to pa-
tients. The findings from this study will help primary care practition-
ers to appropriately communicate cancer risk information to patients 
and minimize patient anxiety and worries during consultations. This 
paper addresses the issue of how best to communicate cancer risk 
information to patients presenting to primary care with symptoms 
which could be those of cancer. Further research on other barriers 
and facilitators to implementation of cancer risk assessment tools, 
with particular reference to QCancer, should be conducted.
5  | CONCLUSION
Communication strategies suggested by participants in this study 
could be used to enhance the discourse between patients and practi-
tioners when using cancer risk assessment tools during primary care 
consultations. As recognized in the Risk Analysis Framework that 
informed this study, the different communication strategies may be 
combined as appropriate to enhance communication in this context.
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